Herbamine 8 X Liquid is a Health Canada–registered human drug (DIN 00226246) held by Dr Reckeweg And Co, containing Arsenic Trioxide. Health Canada lists its status as Cancelled Post Market (status date 23 Oct 1997). Nexara Health has matched 116 registrations of Arsenic Trioxide across 23 other regulated markets, 3 of them in the same strength and dosage form.

Health Canada registration

Arsenic Trioxide registered in other markets

116 registrations of the same molecule in 23 national registries outside Canada (first 72 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Arsenic Trioxide worldwide →

Regulator price references for Arsenic Trioxide

Published list or reimbursement prices for Arsenic Trioxide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Herbamine (DIN 00226246) marketed in Canada?

No. Health Canada lists DIN 00226246 as Cancelled Post Market as of 23 Oct 1997.

Who holds the Canadian licence for this product?

Dr Reckeweg And Co is the company of record in the Health Canada Drug Product Database.

Is Arsenic Trioxide registered outside Canada?

Yes — Nexara Health has matched 116 registrations in 23 other markets, including 3 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00226246, status date 1997-10-23; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, HPRA, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00226246, status date 1997-10-23; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, HPRA, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS, SFDA.

Health Canada Drug Product Database (DPD), DIN 00226246, status date 1997-10-23; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, HPRA, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA, PBS, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.